| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ARGENX | 7 | 10 | +0,76 % | ||
| AB INBEV | 6 | 30 | -0,74 % | ||
| MELEXIS | 1 | 4 | +0,91 % | ||
| ELIA GROUP | 1 | 4 | -1,49 % | ||
| AGEAS | 1 | 1 | +0,49 % | ||
| GBL | 1 | 1 | 0,00 % | ||
| UMICORE | - | 2 | +0,16 % | ||
| KBC GROEP NV | - | 1 | +1,10 % | ||
| MONTEA | - | 1 | +0,99 % | ||
| AEDIFICA | - | 1 | -0,15 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:57 | AB InBev kauft Minderheitsanteil an US-Dosenwerken für 3 Mrd USD zurück | 184 | Dow Jones News | DJ AB InBev kauft Minderheitsanteil an US-Dosenwerken für 3 Mrd USD zurück
Von Aimee Look
DOW JONES--Der Budweiser-Brauer Anheuser-Busch InBev kauft eine Minderheitsbeteiligung an seinen Metallbehälterwerken... ► Artikel lesen | |
| 08:35 | AB InBev buys back stake in US-based metal container plants for $3 billion | 5 | Reuters | ||
| 08:20 | AB Inbev kauft Minderheitsbeteiligung an US-Metallbehälterwerken zurück | 230 | dpa-AFX | BRÜSSEL (dpa-AFX) - Der Bierbrauer AB Inbev kauft eine 49,9-prozentige Minderheitsbeteiligung an seinen Dosenwerken in den USA zurück. Verkäufer ist ein Konsortium institutioneller Investoren unter... ► Artikel lesen | |
| 08:18 | ANHEUSER-BUSCH INBEV SA/NV - AB InBev Announces Exercise of Right to Reacquire Minority Stake in its US-based Metal Container Plants | 4 | SENS | ||
| 07:54 | Budweiser maker Anheuser-Busch rebuys U.S. container plant stake for $3 billion | 5 | Seeking Alpha | ||
| 07:48 | AB InBev Exercises Right To Reacquire Minority Stake In US-based Metal Container Plants | 200 | AFX News | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Anheuser-Busch InBev (BUD) said it has exercised its right to reacquire the 49.9% minority stake in AB InBev's US-based metal container plants from a consortium... ► Artikel lesen | |
| Mo | As Vyvgart empire expands, argenx CEO passes reins to operating chief Karen Massey | 5 | FiercePharma | ||
| Mo | GBL: GBL - Transactions on GBL shares 05-01-2026 | 1 | Euronext | ||
| Mo | Melexis N.V.: Melexis: update on the share buy-back program | 3 | GlobeNewswire (USA) | ||
| Mo | Novo launches Wegovy pill; Argenx to swap CEOs | 17 | BioPharma Dive | ||
| Mo | Ageas announces intragroup repurchase of own shares | 2 | GlobeNewswire (USA) | ||
| Mo | Argenx-Aktie: TD Cowen bekräftigt "Buy"-Rating nach Ankündigung eines Führungswechsels | 4 | Investing.com Deutsch | ||
| Mo | Argenx stock holds steady as TD Cowen reiterates Buy rating | 7 | Investing.com | ||
| Mo | Finanzierungen: Eurogrid, Telekom Austria, AMS-Osram | 75 | Finance Magazin | ||
| Mo | argenx announces CEO transition | 5 | Seeking Alpha | ||
| Mo | ARGENX SE - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| Mo | Argenx names new chief executive | 4 | belga | ||
| Mo | Syensqo Completes Divestment Of Oil & Gas Business Unit; Mike Radossich Takes Over As CEO | 1 | RTTNews | ||
| Mo | Argenx Names Karen Massey As CEO, Tim Van Hauwermeiren To Become Board Chairman | 258 | AFX News | BRUSSELS (dpa-AFX) - argenx SE (ARGX), an immunology company, on Monday announced that Karen Massey, the company's current Chief Operating Officer, will transition to Chief Executive Officer... ► Artikel lesen | |
| Mo | argenx SE: argenx Announces Leadership Transition Marking Next Evolution of Growth | 5 | GlobeNewswire (USA) |